Filana Therapeutics Inc (FLNA) Stock Price, Quote & News

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its na...

Industry: Biotechnology

Sector: Healthcare

Phone: 512 501 2444

Website: www.filanatx.com

Address:

6801 N. Capital of Texas Highway, Building 1, Austin, United States

BioGLovesMe Sep. 10 at 10:49 PM

$FLNA When do they get the delisting notice?

1 · Reply

Shawshank_book_keeper Sep. 10 at 1:58 PM

$FLNA

0 · Reply

JumpStarting Sep. 9 at 8:40 PM

$FLNA investors: Important Clarification — NOT a new financial hit! • 💰 Already Paid: The $31.25M settlement was already funded into escrow on July 23, 2026, and previously recorded as a loss. • 📑 Current Development: The settlement now appears to be moving into the investor claims & recovery process. • 🎯 Focus Remains: The claims timeline, the separate 2024 securities case, and the underlying TSC/FDA program.

0 · Reply

BioGLovesMe Sep. 9 at 7:51 PM

$FLNA What's worse than an open-ended lotto ticket? Pretty much any pre-revenue junk biotech, especially one that has failed twice to bring a drug to market, and is on its third iteration.

0 · Reply

11thestate Sep. 9 at 1:21 PM

Imagine buying $SAVA (now $FLNA ) at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $SAVA investors out there, we’ve got some important news: an investor settlement is now open for claims from shareholders who purchased shares between 2020 and 2023. You can check if you’re eligible and claim your share: https://11th.com/cases/cassava-investor-settlement

1 · Reply

Iam4our Sep. 8 at 2:14 PM

$FLNA Interested now… ✅Almost at entry point

0 · Reply

GangsterX Sep. 3 at 1:06 PM

$FLNA buy between .75-.95 and hold until fda clinical lift news. It has to be out in Q4.

1 · Reply

BioGLovesMe Sep. 2 at 3:29 PM

$FLNA @Bricktop200 please tell us your average

1 · Reply

JumpStarting Sep. 1 at 2:42 PM

$FLNA Don't confuse macro risk-off with a change in the thesis. Market is bleeding on oil, geopolitics, & yields—Small-cap biotech is getting hit especially hard. The facts remain: • Focused clinical program • Zero debt • $36M–$40M year-end cash (after $31.25M escrow) FDA clinical hold is the big risk, but also the ultimate catalyst. $XBI

0 · Reply

fedeperu Aug. 31 at 5:44 PM

$FLNA better days are coming...

2 · Reply

Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jul 29, 2026, 8:30 AM EDT - 6 weeks ago

Filana Therapeutics Earnings release: Q2 2026

Jul 29, 2026, 8:30 AM EDT - 6 weeks ago

Filana Therapeutics Quarterly report: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 6 weeks ago

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

Jul 29, 2026, 7:00 AM EDT - 6 weeks ago

Filana Therapeutics Slides: Corporate presentation

Jun 11, 2026, 9:30 AM EDT - 3 months ago

Filana Therapeutics Transcript: AGM 2026

2026-05-26T13:58:44.000Z - 3 months ago

Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot

2026-05-26T12:40:15.000Z - 3 months ago

Filana Therapeutics resumed with a Buy at Maxim

May 7, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

May 7, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Filana Therapeutics Slides: Corporate presentation

May 5, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Filana Therapeutics Proxy statement: Proxy filing

2026-04-15T12:20:15.000Z - 5 months ago

Filana Therapeutics publishes simufilam preclinical data

2026-03-19T19:25:18.000Z - 5 months ago

Filana Therapeutics management to meet with Maxim

2026-03-12T12:13:27.000Z - 6 months ago

Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year

2026-03-12T12:12:53.000Z - 6 months ago

Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M

Mar 12, 2026, 8:00 AM EDT - 6 months ago

Filana Therapeutics Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 6 months ago

Filana Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 7:00 AM EDT - 6 months ago

Filana Therapeutics Slides: Investor presentation

Feb 19, 2026, 8:52 AM EST - 6 months ago

Cassava Sciences says US DOJ has closed investigation into company

Dec 24, 2025, 11:51 AM EST - 8 months ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 13, 2025, 7:00 AM EST - 10 months ago

Filana Therapeutics Registration statement: Registration Filing

Nov 12, 2025, 8:00 AM EST - 10 months ago

Filana Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 10 months ago

Filana Therapeutics Earnings release: Q3 2025

Oct 22, 2025, 4:05 PM EDT - 10 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Sep 8, 2025, 5:00 PM EDT - 1 year ago

Filana Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 4, 2025, 7:30 AM EDT - 1 year ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Jun 30, 2025, 7:00 AM EDT - 1 year ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q1 2025

May 1, 2025, 7:30 AM EDT - 1 year ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Apr 21, 2025, 4:30 PM EDT - 1 year ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Mar 26, 2025, 3:49 PM EDT - 1 year ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 3, 2025, 7:30 AM EST - 1 year ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Annual report: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Earnings release: Q4 2024

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

BioGLovesMe Sep. 10 at 10:49 PM

$FLNA When do they get the delisting notice?

1 · Reply

Shawshank_book_keeper Sep. 10 at 1:58 PM

$FLNA

0 · Reply

JumpStarting Sep. 9 at 8:40 PM

0 · Reply

BioGLovesMe Sep. 9 at 7:51 PM

$FLNA What's worse than an open-ended lotto ticket? Pretty much any pre-revenue junk biotech, especially one that has failed twice to bring a drug to market, and is on its third iteration.

0 · Reply

11thestate Sep. 9 at 1:21 PM

1 · Reply

Iam4our Sep. 8 at 2:14 PM

$FLNA Interested now… ✅Almost at entry point

0 · Reply

GangsterX Sep. 3 at 1:06 PM

$FLNA buy between .75-.95 and hold until fda clinical lift news. It has to be out in Q4.

1 · Reply

BioGLovesMe Sep. 2 at 3:29 PM

$FLNA @Bricktop200 please tell us your average

1 · Reply

JumpStarting Sep. 1 at 2:42 PM

0 · Reply

fedeperu Aug. 31 at 5:44 PM

$FLNA better days are coming...

2 · Reply

BioGLovesMe Aug. 31 at 5:23 PM

$FLNA Congrats bulls @Bricktop200 ! Buy more!

1 · Reply

Shawshank_book_keeper Aug. 31 at 8:39 AM

$FLNA SIMIFULAM PT125 .. drug is dangerous… placebo pills have proven to be more effective and safer Just take a look at this cassava shareholder who is still living in denial

0 · Reply

Shawshank_book_keeper Aug. 26 at 8:29 PM

$FLNA how are the warrants!!! 😆 is Alzheimer’s still on the table?

2 · Reply

11thestate Aug. 25 at 1:43 PM

$SAVAW (now $FLNA ) investors, we know you’ve taken a hit. Now’s the time to find out that you can do something about those losses. Check out what we’ve got for you: https://11th.com/cases/cassava-investor-settlement

0 · Reply

Shawshank_book_keeper Aug. 23 at 9:33 PM

$FLNA RECYCLED GARBAGE!!!!

0 · Reply

Shawshank_book_keeper Aug. 23 at 4:39 PM

$FLNA pain therapeutic… cassava sciences… filana therapeutics….. (_____)

0 · Reply